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Introduction: Invasive fungal infections are alarmingly common in intensive care unit patients; invasive fungal
infections are associated with increased morbidity and mortality. Risk factors are the increased use of indwelling
central venous catheters, the use of broad spectrum antibiotics, parenteral nutrition, renal replacement therapy and
immunosuppression. Diagnosis of these infections might be complicated, requiring tissue cultures. In addition,
therapy of invasive fungal infections might be difficult, given the rising resistance of fungi to antifungal agents.
Case presentation: We describe the case of a 28-year-old Greek man with yeast central nervous system infection.
Conclusions: Difficult-to-treat fungal infections may complicate the clinical course of critically ill patients and
render their prognosis unfavorable. This report presents a case that was rare and difficult to treat, along with a
thorough review of the investigation and treatment of these kinds of fungal infections in critically ill patients.
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Invasive fungal infections are increasingly common in
intensive care unit (ICU) patients and are associated
with prolonged hospitalization duration and increased
mortality [1]. The worldwide Extended Prevalence of
Infection in Intensive Care study conducted in 2007
showed that almost 20% of all isolated pathogens in ICU
patients were fungi, with Candida spp. ranking fourth
after Staphylococcus spp., Pseudomonas spp. and Escheri-
chia coli. Candida spp. were the most frequently isolated
yeasts, responsible for almost 88% of fungal infections.
Of interest, there is an increasing trend of fungal infec-
tions caused by non-albicans Candida species, relatively
resistant to commonly used antifungal agents [2,3]. The
cited attributable mortality for Candida infections varies
from 5% to 71% [4]. The increased incidence of fungal
infections in ICU patients may be attributed to a variety
of reasons such as the increasing incidence of immuno-
compromised patients requiring ICU admission, the* Correspondence: ffrantzeska@gmail.com
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of invasive medical practices required in ICUs [5]. This
report presents a difficult to treat central nervous system
(CNS) fungal infection in a medical-surgical ICU (MSICU)
of a tertiary hospital.Case presentation
A 28-year-old Greek man was admitted to the neuro-
logical department of a tertiary hospital with drop of the
right corner of his mouth, left eyelid ptosis, bilateral vis-
ual field defects, diplopia, headache, fever and dizziness.
He had been diagnosed with Hodgkin’s lymphoma 18
months earlier and had achieved complete remission
after eight courses of chemotherapy. Four months prior
to this admission recurrence of the disease was diag-
nosed, and he underwent new courses of salvage treat-
ment with etoposide, methylprednisolone, high-dose
cytarabine and cisplatin (ESHAP). The last course was
performed a month before the present admission and a
follow-up positron emission tomography scan showed
minimal residual disease. He was not receiving any anti-
fungal prophylaxis. On his admission, a brain contrast-
enhanced computed tomography (CT) scan was normalntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 (a and b) A brain computed tomography scan showing blurred bony structures of the floor of the mouth and the tongue,
consolidation of left maxillary sinus and accompanying invasion of the maxillary bone.
Figure 2 Gram stain (original magnification: ×1000). Yeast cells
found after examination of multiple cerebrospinal fluid smears.
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with 175 leukocytes/mm3 (lymphocytes 98%), an ele-
vated protein level of 128mg/dL and a reduced glucose
level of 35mg/dL (120mg/dL in serum). Gram stain, cul-
tures, Cryptococcus antigen and polymerase chain reac-
tion (PCR) for herpes viruses were negative. Blood
cultures were negative. Magnetic resonance imaging of
his brain disclosed high signal intensity of fast fluid-
attenuated inversion recovery, involving periventricular
and subcortical gray matter of bilateral brain hemi-
spheres, hippocampus, internal capsule bilaterally, thal-
ami, pons, cerebral peduncles, substantia nigra of
midbrain, middle and inferior cerebellar peduncles, and
cervical spinal cord, without hemorrhage nor restricted
diffusion pattern (Figures 1a and 1b). After administra-
tion of a paramagnetic substance, leptomeningeal con-
trast enhancement was noticed, and the above lesions
accentuated. A brain biopsy was performed and the
pathologic examination of dura mater specimens showed
yeast cells (periodic acid–Schiff histochemical stain). A
panfungal PCR assay was arranged for brain tissue speci-
mens. A second lumbar puncture was performed: CSF
cell counts showed 100 leukocytes/mm3 (lymphocytes
85%), glucose 40mg/dL (120mg/dL in serum) and pro-
tein level 100mg/dL. Gram stain, India ink preparation
and cultures remained negative. However, yeast cells
were observed on a second Gram stain examination of
CSF (Figure 2). A diagnosis of “yeast” CNS infection was
established and he was empirically treated with liposo-
mal amphotericin B (450mg once a day intravenous) and
flucytosine (100mg/kg/day divided into four oral doses).
Five days later his level of consciousness deteriorated
and tracheal intubation was performed because of
impending coma. He was admitted to ICU and a new
brain CT was performed showing multiple ring-like en-
hanced lesions with peripheral edema affecting the graymatter of l hemispheres bilaterally. A week later, while
he was still in a comatose condition, he suddenly pre-
sented dilatation of pupils, predominately of his left one,
with no reaction to light. A new brain CT showed diffuse
brain edema affecting mainly his posterior cranial fossa,
indicating tentorial herniation. Despite the administered
osmotherapy with dexamethasone and mannitol, he de-
veloped cardiac asystole on the same day and died. An in-
house real-time panfungal PCR assay (LightCycler,
Roche®) performed following automated deoxyribonucleic
acid (DNA) extraction (Maxwell 16®, Promega) from fresh
brain tissue specimens was positive for yeast DNA.
Discussion
This report describes a yeast-related CNS infection of a
young immunocompromised man. Yeasts are pathogenic
in patients with hematological neoplasms (as in our pa-
tient), solid neoplasms, acquired immunodeficiency
Table 1 Previously reported cohorts of central nervous system yeast infections
Author and reference number Cases (n) Type of central nervous system infection (n) Causative fungus
Levy RM et al. [11] 5 Brain abscesses (4) Candida species
J Neurosurg. 1985 Apr;62 (4):475-95. Meningoencephalitis (1)
Pappas PG et al. [6] 14 Meningitis (14) C. albicans (13)
C. tropicalis (1)
Dorko E et al. [12] 13 Meningitis (13) C. albicans (54%)
Folia Microbiol (Praha). 2002;47 (6):732-6. C. parapsilosis (23%)
C. tropicalis (15%)
C. krusei (8%)
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organs. In our case, blood cultures were negative, as
might happen in 50% of CNS fungal infections. However,
diagnosis was confirmed by microscopy. In our patient
the PCR assay of brain tissue was yeast positive. Ampho-
tericin B is the drug of choice, in the absence of positive
cultures and hence inability to perform susceptibility
testing [6,7]. Despite treatment, he died. More studies
are required in order to clarify the exact physiological
mechanism of yeast CNS infection and the appropriate
treatment. The entity is uncommon but affects predom-
inantly neonates, neurosurgical patients and immuno-
suppressed patients. It has been described in patients
with granulomatous disease, myeloperoxidase deficiency,
severe combined immunodeficiency, human immuno-
deficiency virus infection, organ transplantation and
lymphoma [8]. Fungemia might precede CNS infection,
while direct inoculation of the fungus may occur, for ex-
ample after placement of CNS prostheses [8]. However,
in our case, blood cultures were negative, as might hap-
pen in 50% of fungemias. Candida albicans accounts for
70% to 100% of all Candida CNS infection cases [9].
Table 1 depicts the previously reported cases of Candida
CNS infections. These may include cerebral microabs-
cesses, manifesting as diffuse encephalopathy, or cerebral
abscesses with focal neurologic signs, and meningitis, as
in our case [9]. A positive CSF culture establishes the diag-
nosis of fungal meningitis. However, in cases of failure to
isolate a pathogen, perhaps because of the small inoculum
size and slow growth of the yeast [8], a brain biopsy might
be considered. Recommended appropriate therapy for
CNS candidiasis is liposomal amphotericin B (3 to 5mg/
kg) with or without 5-flucytosine 25mg/kg every 6 hours,
for several weeks, followed by fluconazole 6 to 12mg/kg
daily [8]. Despite the existing evidence for synergistic ac-
tion between amphotericin and fluconazole, there is no
confirmed clinical superiority of combination therapy
for Candida yeast meningitis [10]. Despite appropriate
combination treatment our patient died because of mul-
tiple brain lesions leading to diffuse brain edema. As
autopsy was denied, confirmation of yeast involvementwas achieved by histology and direct microscopic
examination.Conclusions
This is a report of a critically ill patient with an invasive
CNS fungal infection in a tertiary hospital MSICU. Inva-
sive fungal infections pose a difficult problem for the
intensivist, owing both to the nature of the infection
and the difficulty in diagnosis and treatment, and to the
comorbidities of the critically ill. A multidisciplinary
approach is frequently required, involving a combination
of antifungal agents as well as surgical management
where indicated. However, the mortality of invasive fun-
gal infections in the ICU remains high in spite of efforts
for prompt diagnosis and treatment.Consent
Written informed consent was obtained from the pa-
tient’s next of kin for publication of this case report and
any accompanying images. A copy of the written consent
is available for review by the Editor-in-Chief of this
journal.
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